{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T12:40:31Z","timestamp":1773751231158,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30-AI 060354"],"award-info":[{"award-number":["P30-AI 060354"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infection with the Human Immunodeficiency Virus (HIV) dramatically increases the risk of developing active tuberculosis (TB). Several studies have indicated that co-infection with TB increases the risk of HIV progression and death. Sub-Saharan Africa bears the brunt of these dual epidemics, with about 2.4 million HIV-infected people living with TB. The main objective of our study was to assess whether the pre-HAART CD4+ T-lymphocyte counts and percentages could serve as biomarkers for post-HAART treatment immune-recovery in HIV-positive children with and without TB co-infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The data analyzed in this retrospective study were collected from a cohort of 305 HIV-infected children being treated with HAART. A Lehmann family of ROC curves were used to assess the diagnostic performance of pre- HAART treatment CD4+ T-lymphocyte count and percentage as biomarkers for post-HAART immune recovery. The Kaplan\u2013Meier estimator was used to compare differences in post-HAART recovery times between patients with and without TB co-infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that the diagnostic performance of both pre-HARRT treatment CD4+ T-lymphocyte count and percentage was comparable and achieved accuracies as high as 74%. Furthermore, the predictive capability of pre-HAART CD4+ T-lymphocyte count and percentage were slightly better in TB-negative patients. Our analyses also indicate that TB-negative patients have a shorter recovery time compared to the TB-positive patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pre-HAART CD4+ T-lymphocyte count and percentage are stronger predictors of immune recovery in TB-negative pediatric patients, suggesting that TB co-infection complicates the treatment of HIV in this cohort. These findings suggest that the detection and treatment of TB is essential for the effectiveness of HAART in HIV-infected pediatric patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05458-w","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T03:02:59Z","timestamp":1602730979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection"],"prefix":"10.1186","volume":"20","author":[{"given":"Vivek","family":"Gopalakrishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8572-1944","authenticated-orcid":false,"given":"Musie","family":"Ghebremichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"5458_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS. Global AIDS monitoring 2019: indicators for monitoring the 2016 political declaration on ending AIDS. 2018."},{"key":"5458_CR2","unstructured":"Health TNI Of. Clinical and Laboratory Monitoring of Pediatric HIV Infection https:\/\/aidsinfo.nih.gov\/guidelines\/brief-html\/2\/pediatric-arv\/59\/clinical-and-laboratory-monitoring-of-pediatric-hiv-infection. Accessed 5 June 2020."},{"key":"5458_CR3","unstructured":"Joint United Nations Programme on HIV\/AIDS. UNAIDS Data 2019. 2019. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2019-UNAIDS-data_en.pdf."},{"key":"5458_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-3156.2010.02669.x","volume":"16","author":"R Zachariah","year":"2011","unstructured":"Zachariah R, Reid SD, Chaillet P, Massaquoi M, Schouten EJ, Harries AD. Viewpoint: why do we need a point-of-care CD4 test for low-income countries?: why do we need a point-of-care CD4 test for low-income countries? Tropical Med Int Health. 2011;16:37\u201341.","journal-title":"Tropical Med Int Health"},{"key":"5458_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s11517-010-0630-1","volume":"48","author":"R Malkin","year":"2010","unstructured":"Malkin R, Keane A. Evidence-based approach to the maintenance of laboratory and medical equipment in resource-poor settings. Med Biol Eng Comput. 2010;48:721\u20136.","journal-title":"Med Biol Eng Comput"},{"key":"5458_CR6","first-page":"4","volume":"6","author":"JN Nkengasong","year":"2004","unstructured":"Nkengasong JN, Adje-Toure C, Weidle PJ. HIV antiretroviral drug resistance in Africa. AIDS Rev. 2004;6:4\u201312.","journal-title":"AIDS Rev"},{"key":"5458_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jama.296.3.292","volume":"296","author":"P Gona","year":"2006","unstructured":"Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff MC, Nachman SA, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296:292.","journal-title":"JAMA."},{"key":"5458_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","volume":"24","author":"CK Kwan","year":"2011","unstructured":"Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human Syndemic. Clin Microbiol Rev. 2011;24:351\u201376.","journal-title":"Clin Microbiol Rev"},{"key":"5458_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EL Corbett","year":"2003","unstructured":"Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009.","journal-title":"Arch Intern Med"},{"key":"5458_CR10","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1086\/651492","volume":"50","author":"H Getahun","year":"2010","unstructured":"Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection\u2013associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50:S201\u20137.","journal-title":"Clin Infect Dis"},{"key":"5458_CR11","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1086\/651475","volume":"50","author":"KH Mayer","year":"2010","unstructured":"Mayer KH, Dukes HC. Synergistic pandemics: confronting the global HIV and tuberculosis epidemics. Clin Infect Dis. 2010;50:S67\u201370.","journal-title":"Clin Infect Dis"},{"key":"5458_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.300.4.423","volume":"300","author":"DV Havlir","year":"2008","unstructured":"Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008;300:423\u201330.","journal-title":"JAMA"},{"key":"5458_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/375220","volume":"37","author":"EL Korenromp","year":"2003","unstructured":"Korenromp EL, Scano F, Williams BG, Dye C, Nunn P. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis. 2003;37:101\u201312.","journal-title":"Clin Infect Dis"},{"key":"5458_CR14","first-page":"263","volume":"4","author":"AM McDonnell","year":"2013","unstructured":"McDonnell AM, Dang CH. Basic review of the cytochrome p450 system. J Adv Pract Oncol. 2013;4:263\u20138.","journal-title":"J Adv Pract Oncol"},{"issue":"Supplement_3","key":"5458_CR15","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1093\/clinids\/5.Supplement_3.S407","volume":"5","author":"W Wehrli","year":"1983","unstructured":"Wehrli W. Rifampin: mechanisms of action and resistance. Clin Infect Dis. 1983;5(Supplement_3):S407\u201311.","journal-title":"Clin Infect Dis"},{"key":"5458_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1086\/380794","volume":"38","author":"US Justesen","year":"2004","unstructured":"Justesen US, Andersen AB, Klitgaard NA, Brosen K, Gerstoft J, Pedersen C. Pharmacokinetic interaction between rifampin and the combination of Indinavir and low-dose ritonavir in HIV-infected patients. Clin Infect Dis. 2004;38:426\u20139.","journal-title":"Clin Infect Dis"},{"key":"5458_CR17","volume-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization; 2010. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599191_eng.pdf. Accessed 26 May 2020."},{"key":"5458_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0971-3026.161431","volume":"25","author":"AS Bhalla","year":"2015","unstructured":"Bhalla AS, Goyal A, Guleria R, Gupta AK. Chest tuberculosis: radiological review and imaging recommendations. Indian J Radiol Imaging. 2015;25:213\u201325.","journal-title":"Indian J Radiol Imaging"},{"key":"5458_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5409\/wjcp.v2.i4.70","volume":"2","author":"PT Veedu","year":"2013","unstructured":"Veedu PT, Bhalla AS, Vishnubhatla S, Kabra SK, Arora A, Singh D, et al. Pediatric vs adult pulmonary tuberculosis: a retrospective computed tomography study. World J Clin Pediatr. 2013;2:70\u20136.","journal-title":"World J Clin Pediatr"},{"issue":"Suppl 1","key":"5458_CR20","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-2334-14-S1-S5","volume":"14","author":"E Venturini","year":"2014","unstructured":"Venturini E, Turkova A, Chiappini E, Galli L, de Martino M, Thorne C. Tuberculosis and HIV co-infection in children. BMC Infect Dis. 2014;14(Suppl 1):S5.","journal-title":"BMC Infect Dis"},{"key":"5458_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/896040","volume":"2011","author":"L Renner","year":"2011","unstructured":"Renner L, Prin M, Li F-Y, Goka B, Northrup V, Paintsil E. Time to and predictors of CD4+ T-lymphocytes recovery in HIV-infected children initiating highly active antiretroviral therapy in Ghana. AIDS Res Treat. 2011;2011:1\u20139.","journal-title":"AIDS Res Treat"},{"key":"5458_CR22","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1080\/02664763.2017.1420758","volume":"45","author":"M Ghebremichael","year":"2018","unstructured":"Ghebremichael M, Habtemicael S. Effect of tuberculosis on immune restoration among HIV-infected patients receiving antiretroviral therapy. J Appl Stat. 2018;45:2357\u201364.","journal-title":"J Appl Stat"},{"key":"5458_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/infdis\/165.2.352","volume":"165","author":"DS Stein","year":"1992","unstructured":"Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis. 1992;165:352\u201363.","journal-title":"J Infect Dis"},{"key":"5458_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/0272989X09360067","volume":"30","author":"M G\u00f6nen","year":"2010","unstructured":"G\u00f6nen M, Heller G. Lehmann family of ROC curves. Med Decis Mak. 2010;30:509\u201317.","journal-title":"Med Decis Mak"},{"key":"5458_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/INF.0b013e3181693892","volume":"27","author":"E Paintsil","year":"2008","unstructured":"Paintsil E, Ghebremichael M, Romano S, Andiman WA. Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression. Pediatr Infect Dis J. 2008;27:629\u201335.","journal-title":"Pediatr Infect Dis J"},{"key":"5458_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.qai.0000152400.36723.85","volume":"39","author":"MS Dworkin","year":"2005","unstructured":"Dworkin MS, Adams MR, Cohn DL, Davidson AJ, Buskin S, Horwitch C, et al. Factors that complicate the treatment of tuberculosis in hiv-infected patients. J Acquir Immune Defic Syndr. 2005;39:464\u201370.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5458_CR27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1086\/500842","volume":"193","author":"European Collaborative Study","year":"2006","unstructured":"European Collaborative Study. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis. 2006;193:954\u201362.","journal-title":"J Infect Dis"},{"key":"5458_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/infdis\/jir787","volume":"205","author":"J Lewis","year":"2012","unstructured":"Lewis J, Walker AS, Castro H, De Rossi A, Gibb DM, Giaquinto C, et al. Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis. 2012;205:548\u201356.","journal-title":"J Infect Dis"},{"key":"5458_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3844\/jmssp.2019.55.64","volume":"15","author":"M Ghebremichael","year":"2019","unstructured":"Ghebremichael M, Michael H, Tubbs J, Paintsil E. Comparing the diagnostics accuracy of CD4+ T-lymphocyte count and percent as a surrogate markers of pediatric HIV disease. J Math Stat. 2019;15:55\u201364.","journal-title":"J Math Stat"},{"key":"5458_CR30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jama.279.10.756","volume":"279","author":"PE Palumbo","year":"1998","unstructured":"Palumbo PE. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA. 1998;279:756.","journal-title":"JAMA"},{"key":"5458_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/169.1.28","volume":"169","author":"MD Hughes","year":"1994","unstructured":"Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis. 1994;169:28\u201336.","journal-title":"J Infect Dis"},{"key":"5458_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2249.2002.01732.x","volume":"127","author":"B-S Choi","year":"2002","unstructured":"Choi B-S, Park Y-K, Lee J-S. The CD28\/HLA-DR expressions on CD4 + T but not CD8 + T cells are significant predictors for progression to AIDS. Clin Exp Immunol. 2002;127:137\u201344.","journal-title":"Clin Exp Immunol"},{"key":"5458_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1086\/504718","volume":"194","author":"M Goicoechea","year":"2006","unstructured":"Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, et al. Determinants of CD4 + T cell recovery during suppressive antiretroviral therapy: Association of Immune Activation, T cell maturation markers, and cellular HIV-1 DNA. J Infect Dis. 2006;194:29\u201337.","journal-title":"J Infect Dis"},{"key":"5458_CR34","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1097\/QAD.0b013e32834c4ac1","volume":"25","author":"PW Hunt","year":"2011","unstructured":"Hunt PW, Cao HL, Muzoora C, Ssewanyana I, Bennett J, Emenyonu N, et al. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS. 2011;25:2123\u201331.","journal-title":"AIDS"},{"key":"5458_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12348-016-0110-3","volume":"6","author":"TH Yeo","year":"2016","unstructured":"Yeo TH, Yeo TK, Wong EP, Agrawal R, Teoh SC. Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy\u2014a 5-year study from Singapore. J Ophthal Inflamm Infect. 2016;6:41.","journal-title":"J Ophthal Inflamm Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05458-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05458-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05458-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T10:03:22Z","timestamp":1634292202000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05458-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5458"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05458-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-47535\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-47535\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-47535\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-47535\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by both the Yale University Human Investigation Committee and the University of Ghana Medical School.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Musie Ghebremichael is an editorial board member of BMC Infectious Diseases journal. Other authors do not have a commercial or other association that might pose a conflict of interest, i.e., authors declare that they have no competing interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"756"}}